NP/FP Rheumatology Outreach Program

66
Improving Quality of Care in Chronic Disease Dr. Sherry Rohekar September 10, 2009

description

NP/FP Rheumatology Outreach Program. Improving Quality of Care in Chronic Disease Dr. Sherry Rohekar September 10, 2009. Overview. What is the program? Your goals Results of needs assessment Burden of arthritis Approach to arthritis Polyarthritis Acute vs. chronic Monoarthritis - PowerPoint PPT Presentation

Transcript of NP/FP Rheumatology Outreach Program

Page 1: NP/FP Rheumatology Outreach Program

Improving Quality of Care in Chronic Disease

Dr. Sherry RohekarSeptember 10, 2009

Page 2: NP/FP Rheumatology Outreach Program

OverviewWhat is the program?Your goals

Results of needs assessmentBurden of arthritisApproach to arthritis

Polyarthritis Acute vs. chronic

Monoarthritis Septic vs. crystal

Page 3: NP/FP Rheumatology Outreach Program

The Arthritis Expert Program: Why?Many communities in SW Ontario are

underserviced in terms of arthritis careArthritis Experts (AEs) will better support

local health teams in their delivery of complex medical care

Comprised of nurses, nurse practitioners and family physicians who frequently refer patients to rheumatologists at St. Joseph’s Health Care (SJHC) in London

Page 4: NP/FP Rheumatology Outreach Program

The Arthritis Expert Program: What?Will occur over 18 months, with monthly sessionsParticipants may attend sessions at SJHC or

attend monthly telemedicine conferences via computer

At the end of the program, we expect that participants will able to:Identify and triage rheumatologic complaintsConfidently treat some complaintsCo-manage chronic arthritic complaints in

conjunction with rheumatologists at SJHC

Page 5: NP/FP Rheumatology Outreach Program

Course CurriculumTeleconferences / Broadcasting from Telehealth,

to be archived for use for those who can’t attend live

Knowledge assessments – at the beginning and throughout the program

Preceptorships and rounds in some regions – also telecast

Case of the month – each month a case related to the learning will be posted with each candidate giving the answers, and then answers are posted and discussion can occur

Page 6: NP/FP Rheumatology Outreach Program

Course CurriculumInternet discussion boardChart audit –10 MSK patients sometime in

first 6 months, with data extraction tool, to be done 3 times over the course

Attendance at the Education Day (live or via broadcast / DVD) once over the course – offered at various times, usually on a Thursday, scheduled well in advance

Opportunity to do advanced training preceptorship in London (not mandatory)

Page 7: NP/FP Rheumatology Outreach Program

Needs Assessment30 participants; all were NPs

Top 3 Areas: DiagnosisRA, SLE/CTD, PMR/TA: 86.7%Fibromyalgia: 83.3%Back pain: 70%

Top 3 Areas: TreatmentRA: 86.7%SLE: 83.3%PMR/TA: 80%

Page 8: NP/FP Rheumatology Outreach Program

Needs AssessmentOther areas of interest:

Comprehensive approach to MSK exam: 93.3%Medications and monitoring of RA: 90%MSK imaging: 90%Approach to lab tests (i.e. RF, ANA): 76.7%

Page 9: NP/FP Rheumatology Outreach Program

Arthritis Expert Program: Chart Review Data Extraction Form Reviewer: ___________________________ (first name, surname) Date of chart review: ______/_____/________ (day/month/year) Date of last patient visit: ______/_____/________ (day/month/year) Rheumatologic diagnosis (please select all that apply): Rheumatoid arthritis Lupus Osteoarthritis Scleroderma Gout Fibromyalgia Connective Tissue Dz Ankylosing spondylitis Psoriatic arthritis Crohn’s/ulcerative colitis related arthritis Polymyalgia rheumatica/temporal arteritis Vasculitis Sjogren’s syndrome Raynaud’s Other: _____________________ Is this patient being co-managed with a rheumatologist? Yes No Data Collection: Please review the chart and examine if the following have been done. Please check the appropriate box. 1. History of rheumatic condition documented. Yes No Unknown 2. Fatigue level documented. Yes No Unknown 3. Pain level documented. Yes No Unknown 4. Functional impairments documented. Yes N o Unknown 5. Health Assessment Questionnaire completed. Yes No Unknown 6. Renal function documented. Yes No Unknown 7. Hepatic function documented. Yes No Unknown

Page 10: NP/FP Rheumatology Outreach Program

General Arthritis Statistics in Canada4 million Canadians have some form of

arthritis (1 in 6 people).2/3 are women3 in 5 are <65 years old

By 2026, 6 million Canadians will have arthritis.

One of the top 3 most common chronic conditions (with non-food allergies and back problems).

Health Canada. Arthritis in Canada. An Ongoing Challenge. Ottawa: Health Canada, 2003.Perruccio et al. J Epidemiol Community Health 2007;61:1056-61.

Page 11: NP/FP Rheumatology Outreach Program

The Burden of ArthritisMajor outcome of arthritis:

chronic pain reduced mobility decreased level of function

Impact on quality of life: mobility, communication, schooling & employment.

Cost of arthritis was over $4 billion (1998) in health care expenses and loss of productivity.

In 1998, medication accounted for $270 million, or 6% of total arthritis cost. This will increase with the use of biologics.

The Arthritis Society of Canada. Arthroscope. An Ongoing Challenge, 2004.

Page 12: NP/FP Rheumatology Outreach Program

A Chronic and Disabling DiseaseCompared to patients with other chronic

conditions, those with arthritis:Experienced more pain, activity restrictions &

long-term disabilityWere more likely to need help with daily

activitiesReported worse self-rated health, more

disrupted sleep and depressionHave more contacts with healthcare

professionals

Health Canada. Arthritis in Canada. An Ongoing Challenge. Ottawa: Health Canada, 2003.

Page 13: NP/FP Rheumatology Outreach Program

Common Comorbidities in Rheumatic Disease• CVD & Atherosclerosis• Metabolic Syndrome• Fibromyalgia• Peridontal Disease • Effects of Smoking

Page 14: NP/FP Rheumatology Outreach Program

Impact of ComorbiditiesPoorer outcomes (response, remission)Higher morbidityIncreased mortality (e.g., CVD)Potential for drug interactions

Krishnan E, et al. Ann Rheum2005;64:1350-2.Wasko MC. Curr Opin Rheumatol 2004;16:109-13.

Boers M, et al. Arthritis Rheum 2004;50:1734-9.

Page 15: NP/FP Rheumatology Outreach Program
Page 16: NP/FP Rheumatology Outreach Program
Page 17: NP/FP Rheumatology Outreach Program
Page 18: NP/FP Rheumatology Outreach Program

In the 1986 Canadian population.

Page 19: NP/FP Rheumatology Outreach Program

% prevalence in the Ontario population.

Page 20: NP/FP Rheumatology Outreach Program
Page 21: NP/FP Rheumatology Outreach Program
Page 22: NP/FP Rheumatology Outreach Program
Page 23: NP/FP Rheumatology Outreach Program
Page 24: NP/FP Rheumatology Outreach Program

Degenerative vs. InflammatoryThe problem with inflammatory arthritis is in

the lining (synovium) of the jointThe problem with degenerative arthritis is in

the cartilage

Page 25: NP/FP Rheumatology Outreach Program
Page 26: NP/FP Rheumatology Outreach Program

Approach To PolyarthritisWhat is polyarthritis? How is it different

from polyarthralgia?Polyarthritis: swelling, tenderness and warmth

of >4 joints, demonstrated by physical examination

Polyarthralgia: pain in >4 joints without demonstrable inflammation on physical examination

Page 27: NP/FP Rheumatology Outreach Program

Polyarticular SymptomsPolyarticular Symptoms

Acute (<6 wks)Acute (<6 wks) Chronic (>6 wks)Chronic (>6 wks)

InfectionInfection Not InfectionNot Infection

InflammatoryInflammatory Not InflammatoryNot Inflammatory

Page 28: NP/FP Rheumatology Outreach Program

Polyarticular SymptomsPolyarticular Symptoms

Acute (<6 wks)Acute (<6 wks)

InfectionInfection Not InfectionNot Infection

Gonoccocal

Meningococcal

Lyme disease

Acute rheumatic fever

Bacterial endocarditis

ViralRubella

Hepatitis B or C

Parvovirus B19

EBV

HIV

RA

SLE

Reactive arthritis

Psoriatic arthritis

Polyarticular gout

Sarcoidosis

Serum sickness

Page 29: NP/FP Rheumatology Outreach Program

Polyarticular SymptomsPolyarticular Symptoms

Chronic (>6 wks)Chronic (>6 wks)

InflammatoryInflammatory Not InflammatoryNot Inflammatory

RA

SLE

SSc

PM

ReA

PsA

Polyarticular crystal

Enteropathic arthritis

Sarcoid

Vasculitis

PMR

OA

CPPD

Paget’s disease

FM

Benign hypermobility syndrome

Hemochromatosis

Page 30: NP/FP Rheumatology Outreach Program

TimingMigratory Additive Intermittant

Present for few days, remits, then

recurs in other joints

Rheumatic fever

Gonococcal

Lyme disease

Begins in some joints and persists,

then goes on to involve others

RA

PsA

Enteropathic arthritis

SLE

Repeated attacks of polyarthritis with complete

remission between attacks

RA

PsA

ReA

Sarcoid

Polyarthricular gout

Page 31: NP/FP Rheumatology Outreach Program

Approach To Monoarthritis:Acute Hot, Red Monoarthritis1. Infection2. Infection3. Infection4. Gout5. Pseudogout6. Oh, did I mention …. Infection?

Page 32: NP/FP Rheumatology Outreach Program

What do you want to do?Aspirate the joint (i.e. take a sample of

fluid from the joint)IF THE JOINT IS RED, THE TUBES GET

FED!

Page 33: NP/FP Rheumatology Outreach Program

What do you send the fluid for?The 3 C’s

Cell Count: A couple of hoursCulture & Sensitivity: 24-48 hoursCrystals: A couple of hoursGram Stain

Page 34: NP/FP Rheumatology Outreach Program

Septic Arthritis

Acute Bacterial ArthritisMedical

emergency!!

Page 35: NP/FP Rheumatology Outreach Program

Importance Of Diagnosis

Failure to recognize and appropriately treat bacterial septic arthritides may lead to significant rates of morbidity and even mortality Specifically, debilitating destruction of

the joint

Page 36: NP/FP Rheumatology Outreach Program

Importance Of Diagnosis

Failure to recognize and appropriately treat bacterial septic arthritides may lead to significant rates of morbidity and even mortality Specifically, debilitating destruction of

the joint

Page 37: NP/FP Rheumatology Outreach Program

Historical Features

Acute onset of joint pain (may be superimposed on chronic pain)

History of trauma Remember iatrogenic joint aspiration

Monoarticular vs. polyarticular Extra-articular symptoms IV drug use/presence of intravenous

catheters

Page 38: NP/FP Rheumatology Outreach Program

Historical Features

Exposure to STDs Conditions that may decrease patient’s

immunity Liver disease, DM, cancer, complement

deficiencies, hypogammaglobulinemia, immunosuppressive medication

Page 39: NP/FP Rheumatology Outreach Program

Historical Features

Classically, present with complaints of low grade fever (40-60%), pain (75%) and decreased ROM, evolving over days or weeks

Sometimes difficult to distinguish from the presentation of crystal arthropathies Tend to have spiking fevers and chills,

rigors

Page 40: NP/FP Rheumatology Outreach Program

Historical Features

If prosthetic joint infection, course usually low-grade with gradually increasing pain

Usually no significant swelling or fever S. aureus associated with a fulminant

course Devitalized tissues (i.e. hematomas)

more susceptible to bacterial multiplication

Course usually more muted in case of bacteremic spread

Page 41: NP/FP Rheumatology Outreach Program

Historical Features

Tuberculous arthritis has indolent features Usually negative PPD, no signs of past

or present pulmonary TB

Page 42: NP/FP Rheumatology Outreach Program

Physical Findings

Most commonly involved joints: knee (50%), hip (20%), shoulder (8%), ankle (7%), wrists (7%) Elbow, interphalangeal,

sternoclavicular, SI joints 1-4% cases

Page 43: NP/FP Rheumatology Outreach Program

Physical Findings

Erythema and swelling in 90% of cases Warmth and tenderness also essential for

diagnosis Usually an obvious effusion Marked limitation of PROM and AROM Beware of locations where difficult to find:

spine, hip, shoulders Physical findings muted in elderly,

immunocompromised, IVDU and especially those with RA

Page 44: NP/FP Rheumatology Outreach Program

Differential Diagnosis

Crystals (gout, pseudogout) RA Seronegative disease (PsA,

enteropathic arthritis) Reactive arthritis Rheumatic fever Drug-induced arthritis

Page 45: NP/FP Rheumatology Outreach Program

Diagnosis: Acute GoutThe Disease of KingsAcute inflammatory

arthritis caused uric acid crystal deposition in the joint

Page 46: NP/FP Rheumatology Outreach Program

Who gets Gout?First attack in men between the ages of

35 and 50.In women it starts after menopause as

estrogen has a protective effect on the excretion of uric acid.

Page 47: NP/FP Rheumatology Outreach Program

Clinical Features of the AttackStarts quickly and very intensely – over a few

hoursVery painful (Can’t stand the bed sheets

touching it)Swollen, warm, and redMay feel unwell and have an associated feveri.e. it can look just like an infected joint!

Page 48: NP/FP Rheumatology Outreach Program

What Joints does it affect?Usually a single joint in

the lower extremityFirst metatarsophalangeal

(MTP) joint (i.e. the big toe) is affected in 50% of cases

Page 49: NP/FP Rheumatology Outreach Program

Common Risk Factors for GoutImpaired renal functionDiuretics: Lasix & hydrochlorothiazideExcessive Alcohol IntakeFamily historyMale Sex

Page 50: NP/FP Rheumatology Outreach Program

Other Disease Associations“A Disease of Plenty”ObesityHypertension (high blood

pressure)DiabetesHyperlipidemia (high lipids)

Page 51: NP/FP Rheumatology Outreach Program

What “triggers” the Attack?SMARTSSurgeryMechanical InjuryAlcoholRecent IllnessTravel / dehydrationStart/Stop Allopurinol

Page 52: NP/FP Rheumatology Outreach Program

How to Confirm the DiagnosisMust aspirate the joint and find urate

crystals to prove diagnosis (needle shaped)

Urate crystals negatively birefringent in polarized light

Page 53: NP/FP Rheumatology Outreach Program

What Blood Tests Should I Order?Complete Blood Count (CBC)

May see elevated WBCMay see reactive thrombocytosis (increased

platelets)Creatinine (measure renal function)Uric Acid

Levels may be normal during an acute attackFasting GlucoseFasting Lipid Levels

Tryglycerides & cholesterol

Page 54: NP/FP Rheumatology Outreach Program

A Word About Uric AcidThere are lots of people walking around with

elevated uric acid levels (hyperuricemia)Many of these people will not get goutHyperuricemia CANNOT be used to make a

diagnosis of gout!Do not treat isolated hyperuricemia

Page 55: NP/FP Rheumatology Outreach Program

Treatment: Non-PharmacologicRest, ice, and elevate the JointDietary modification

Meat & seafood are BadVegetables & low-fat dairy are good

Reduce alcohol intakeGood hydration

Page 56: NP/FP Rheumatology Outreach Program

PharmacologicIntra-articular corticosteroids

Inject the affected jointOral NSAIDs or COXIBs

Indomethacin 50 mg PO TIDOral colchicine

0.6 mg PO q8h Oral prednisone

50 mg po x 7 days

Page 57: NP/FP Rheumatology Outreach Program

When To Consider Allopurinol1. Recurrent acute episodes of gout affecting

lifestyle; 2. Patients at risk from complications of

treatments required for acute attacks; 3. Patient acceptance of the need for lifelong

medication compliance;4. Uric acid tophaceous deposits

Page 58: NP/FP Rheumatology Outreach Program

AllopurinolDo not start during an acute attackProphylaxis with an NSAID/ColchicineReduce uric acid to lower limit of laboratory

reference range

Xanthine Uric Acid Xanthine Oxidase

ALLOPURINOL inhibits

Page 59: NP/FP Rheumatology Outreach Program

Diagnosis: Acute Pseudogout Acute inflammatory

arthritis caused by calcium pyrophosphate crystals

Page 60: NP/FP Rheumatology Outreach Program

Who gets Pseudogout?Older individualsOften have associated osteoarthritis

Page 61: NP/FP Rheumatology Outreach Program

Clinical Features of the AttackStarts quickly and very intensely Tends to be less intense than gout and takes

longer to reach peak than acute goutVery painful Swollen, warm, and redMay feel unwell and have an associated feveri.e. it can look just like an infected joint!

Page 62: NP/FP Rheumatology Outreach Program

What Joints Does it Affect?Usually a single joint in

the lower extremityKnee is the most common

Page 63: NP/FP Rheumatology Outreach Program

How to Confirm the DiagnosisMust aspirate the joint and find

intracellular calcium pyrophosphate crystals to prove diagnosis (rhomboid shaped)

CPP crystals positively birefringent in polarized light

Page 64: NP/FP Rheumatology Outreach Program

Non-Pharmacologic TreatmentRest, ice, and elevate the jointGood hydration

Page 65: NP/FP Rheumatology Outreach Program

PharmacologicIntra-Articular

Corticosteroids Inject the affected joint

Oral NSAIDs or COXIBsIndomethacin 50 mg PO

TIDOral Prednisone

50 mg po od x 7 days

Page 66: NP/FP Rheumatology Outreach Program

SummaryWe hope to increase teamwork between NPs,

FPs and rheumatologistsCo-management of chronic diseaseContinuing education